HelmholtzZentrum munich
WCMC

Connecting genetic risk to disease endpoints through the human blood plasma proteome

ONLINE SUPPLEMENTARY INFORMATION

Ideogram
Proteome annotation
Locus annotations

Locus 21

Top associations per target

Target cis/​trans Study SNP SNP location Maj/​min allele MAF N βinv seinv Pinv fclog Plog Praw
PCSK7 cis Discovery rs9326248 11:116,999,225 G/T 0.24 995 -0.993 0.040 1.7×10-105 -1.270 3.1×10-80 9.7×10-27
PCSK7 cis Replication rs8521 11:117,067,699 A/G 0.49 337 -0.831 0.050 2.1×10-45 -1.310 1.2×10-32 2×10-16

 

Regional association plots

Proprotein convertase subtilisin/kexin type 7 (PCSK7)

 

Boxplots and histograms for top associations

Proprotein convertase subtilisin/kexin type 7 (PCSK7)

inverse-normalized probe levels log2 transformed probe levels raw probe levels
Discovery study
Replication study

Proprotein convertase subtilisin/kexin type 7 (PCSK7)

Target (abbrv.) PCSK7
Target (full name) Proprotein convertase subtilisin/kexin type 7
Somalogic ID (Sequence ID) SL014069 (4459-68_2)
Entrez Gene Symbol PCSK7
UniProt ID Q16549
UniProt Comment
  • Likely to represent a ubiquitous endoprotease activity within constitutive secretory pathways and capable of cleavage at the RXXX[KR]R consensus motif.
Biomarker applications (based on IPA annotation)
  • unspecified application

All locus annotations are based on the sentinel SNP (rs9326248) and 37 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)

Linked genes

Genes hit or close-by
Potentially regulated genes
eQTL genes
  • PCSK7 proprotein convertase subtilisin/kexin type 7
  • TAGLN transgelin
  • RP11-109L13.1
  • CBLN2 cerebellin 2 precursor
  • SIDT2 SID1 transmembrane family, member 2
  • PAFAH1B2 platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)

 

Results from other genome-wide association studies

Trait P Study Source
cg03276022 (chr11:117069924) 3.3×10-310 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
cg10130564 (chr11:117069873) 3.3×10-310 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
cg11861562 (chr11:117069756) 3.3×10-310 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
cg15534755 (chr11:117069883) 3.3×10-310 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
cg26566898 (chr11:117069915) 3.3×10-310 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
Gene expression of TAGLN in peripheral blood monocytes 6×10-200 20502693 (PMID) GRASP2 eQTL
Gene expression of TAGLN///PCSK7 in blood 4.6×10-184 21829388 (PMID) GRASP2 eQTL
Gene expression of SIDT2 in peripheral blood monocytes 1.4×10-122 20502693 (PMID) GRASP2 eQTL
Gene expression of SIDT2 in blood 4.9×10-85 21829388 (PMID) GRASP2 eQTL
Gene expression of TAGLN (probeID ILMN_1778668) in whole blood 2.3×10-72 22692066 (PMID) GRASP2 eQTL
Gene expression of SIDT2 (probeID ILMN_1791912) in whole blood 4.3×10-31 22692066 (PMID) GRASP2 eQTL
Soluble transferrin receptor 7.3×10-24 21149283 (PMID) GRASP2 nonQTL
Gene expression of PAFAH1B2 [probe ILMN_1778668] in peripheral leukocytes 3.9×10-21 19966804 (PMID) GRASP2 eQTL
cg24619694 (chr11:117070461) 3×10-16 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
Differential splicing of PCSK7 [probeset 3393213] in lymphoblastoid cell lines 5×10-15 19052777 (PMID) GRASP2 eQTL
Gene expression of TAGLN (probeID ILMN_1706783) in temporal cortex in Alzheimer's disease cases and controls 6.3×10-15 22685416 (PMID) GRASP2 eQTL
Gene expression of TAGLN in blood 1.1×10-14 21829388 (PMID) GRASP2 eQTL
Total cholesterol 1.7×10-10 24097068 (PMID) Supplemental file
Triglycerides 2.1×10-10 20686565 (PMID) GRASP2 nonQTL
Gene expression of TAGLN (probeID ILMN_1706783) in temporal cortex in non-Alzheimer's disease samples 7×10-10 22685416 (PMID) GRASP2 eQTL
Gene expression of TAGLN in Fibroblasts 2.7×10-9 19644074 (PMID) GRASP2 eQTL
Gene expression of PCSK7 in peripheral blood monocytes 3.8×10-8 20502693 (PMID) GRASP2 eQTL
Gene expression of TAGLN in blood cells in Celiac disease 6.5×10-8 19128478 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350819] in peripheral blood mononuclear cells 4.7×10-7 19222302 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350803] in peripheral blood mononuclear cells 4.8×10-7 19222302 (PMID) GRASP2 eQTL
Gene expression of SIDT2 in normal prepouch ileum 1.1×10-6 23474282 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350816] in peripheral blood mononuclear cells 1.2×10-6 19222302 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350810] in peripheral blood mononuclear cells 2×10-6 19222302 (PMID) GRASP2 eQTL
Differential exon level expression of PCSK7 [probe 3393204] in peripheral blood mononuclear cells 3.2×10-6 19222302 (PMID) GRASP2 eQTL
Gene expression of TAGLN (probeID ILMN_1706783) in temporal cortex in Alzheimer's disease cases 3.4×10-6 22685416 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350814] in peripheral blood mononuclear cells 5.9×10-6 19222302 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350806] in peripheral blood mononuclear cells 7.1×10-6 19222302 (PMID) GRASP2 eQTL
Differential exon level expression of SIDT2 [probe 3350818] in peripheral blood mononuclear cells 8.9×10-6 19222302 (PMID) GRASP2 eQTL
Gene expression change of TAGLN (ENSG00000149591) in dendritic cells after treatment with Mycobacterium tuberculosis 1.9×10-5 22233810 (PMID) GRASP2 eQTL
Gene expression of SIDT2 [probe 3350775] in peripheral blood mononuclear cells 2.3×10-5 19222302 (PMID) GRASP2 eQTL
Gene expression of TAGLN in CD4+ lymphocytes 2.6×10-5 20833654 (PMID) GRASP2 eQTL
1,6-anhydroglucose 9.2×10-5 24816252 (PMID) gwas.eu via SNiPA
Gene expression of TAGLN [probe 3350830] in peripheral blood mononuclear cells 3.5×10-4 19222302 (PMID) GRASP2 eQTL
LDL cholesterol 3.6×10-4 19060906 (PMID) GRASP2 nonQTL
Advanced age-related macular degeneration 4×10-4 23455636 (PMID) GRASP2 nonQTL